TearSolutions
Virginia startup incorporated in delaware focused on ‘dry eye’, the most common eye disease.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD40—59m (Dealroom.co estimates Mar 2019.)
United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $390k | Convertible | |
$3.0m | Series A | ||
| N/A | N/A | - | |
$8.5m | Series B | ||
$6.4m | Series B | ||
| N/A | $1.5m | Early VC | |
| N/A | $5.6m | Late VC | |
| Total Funding | AUD39.3m | ||
Related Content
Recent News about TearSolutions
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.